PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Five forces analysis PART 06: Geographical segmentation • Global female contraceptive market by geography • Female contraceptive market in Americas • Female contraceptive market in EMEA • Female contraceptive market in APAC PART 07: Product segmentation • Global female contraceptive market by product segmentation • Global female contraceptive market by devices • Global IUD market • Global sterilization market • Global subdermal contraceptive implant market • Global vaginal ring market • Global female condom market • Global non-surgical permanent contraception market • Global contraceptive diaphragm market • Global contraceptive sponge market • Global female contraceptive drug market • Global birth control pill market • Global emergency pill market PART 08: Market drivers PART 09: Impact of drivers PART 10: Market challenges PART 11: Impact of drivers and challenges PART 12: Market trends PART 13: Vendor landscape • Competitive scenario PART 14: Key vendor analysis • Allergan • Merck Millipore • Pfizer • Teva Pharmaceuticals • Other prominent vendors PART 15: Appendix • List of abbreviations PART 16: Explore Technavio   List of Exhibits Exhibit 01: Product offerings Exhibit 02: Global female contraceptive market: An overview Exhibit 03: Advantages and disadvantages of different types of contraceptives Exhibit 04: Effectiveness of female contraceptives Exhibit 05: Global female contraceptive market ($ billions) Exhibit 06: Impact factors of the global female contraceptive market Exhibit 07: Investment opportunity in global female contraceptive market Exhibit 08: Effectiveness of family planning methods Exhibit 09: Top-ranked women health issues 2015 Exhibit 10: Five forces analysis Exhibit 11: Global female contraceptive market by geography 2015-2020 (% share) Exhibit 12: Global female contraceptive market by geography 2015-2020 Exhibit 13: Female contraceptive market in the Americas 2015-2020 ($ billions) Exhibit 14: Percentage of women aged 15-44 using modern contraceptives in US 2015 Exhibit 15: Key leading countries Exhibit 16: Female contraceptive market in EMEA 2015-2020 ($ billions) Exhibit 17: Key leading countries Exhibit 18: Female contraceptive market in APAC 2015-2020 ($ billions) Exhibit 19: Key leading countries Exhibit 20: Global female contraceptive market by product segmentation 2015 (% share) Exhibit 21: Opportunity analysis for global female contraceptive market by product segmentation Exhibit 22: Global female contraceptive device market 2015-2020 ($ billions) Exhibit 23: Global female contraceptive device market by type 2015-2020 Exhibit 24: Global IUD market 2015-2020 ($ millions) Exhibit 25: Global sterilization market 2015-2020 ($ millions) Exhibit 26: Global subdermal contraceptive implant market 2015-2020 ($ millions) Exhibit 27: Global vaginal ring market 2015-2020 ($ millions) Exhibit 28: Global female condom market 2015-2020 ($ millions) Exhibit 29: Global non-surgical permanent contraception market 2015-2020 ($ millions) Exhibit 30: Global contraceptive diaphragm market 2015-2020 ($ millions) Exhibit 31: Global contraceptive sponge market 2015-2020 ($ millions) Exhibit 32: Global female contraceptive drug market 2015-2020 ($ billions) Exhibit 33: Global female contraceptive market by type 2015 and 2020 Exhibit 34: Global birth control pill market 2015-2020 ($ millions) Exhibit 35: Global emergency pill market 2015-2020 ($ millions) Exhibit 36: Key leading countries in emergency pills Exhibit 37: Unplanned pregnancies by region (millions) Exhibit 38: Impact of drivers Exhibit 39: Impact of drivers and challenges Exhibit 40: Non-contraceptive health benefits Exhibit 41: Population of women using birth pills for non-contraceptive reasons Exhibit 42: Competitive parameters in global female contraceptive market Exhibit 43: Strategic success factor of companies Exhibit 44: Key takeaways Exhibit 45: Key takeaways Exhibit 46: Pfizer: Key takeaways

Allergan, Merck Millipore, Pfizer, Teva, Afaxys, Agile Therapeutics, Ansell, Bayer Pharma, Caya, Ferring Pharmaceuticals, Female Health, Fuji Latex, HLL Lifecare, Janssen Pharmaceuticals, Lipocine, Lupin Pharmaceuticals, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser, Syzygy Healthcare, V-Care Pharma